Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia

Advanced Dementia ◽

Imagine that: cholinesterase inhibitor treatment of complex visual hallucinations of unknown aetiology

Cognitive Neuropsychiatry ◽

10.1080/13546805.2021.1941832 ◽

2021 ◽

pp. 1-8

Author(s):

Y. Salih ◽

A. De Angelis ◽

N. A. Poole

Keyword(s):

Visual Hallucinations ◽

Unknown Aetiology ◽

Cholinesterase inhibitor treatment in patients with delirium – Authors' reply

The Lancet ◽

10.1016/s0140-6736(11)60346-2 ◽

2011 ◽

Vol 377 (9769) ◽

pp. 901

Author(s):

Maarten MJ van Eijk ◽

Willem A van Gool ◽

Arjen JC Slooter

Keyword(s):

Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment

Journal of Alzheimer s Disease ◽

10.3233/jad-170497 ◽

2017 ◽

Vol 60 (4) ◽

pp. 1525-1531 ◽

Cited By ~ 3

Author(s):

D.P. Devanand ◽

Cody Lentz ◽

Richard E. Chunga ◽

Adam Ciarleglio ◽

Jennifer M. Scodes ◽

...

Keyword(s):

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Odor Identification ◽

Cortical Activation During Cholinesterase-Inhibitor Treatment in Alzheimer Disease

American Journal of Geriatric Psychiatry ◽

10.1097/00019442-200511000-00012 ◽

2005 ◽

Vol 13 (11) ◽

pp. 1006-1013

Author(s):

Tilo T.J. Kircher ◽

Michael Erb ◽

Wolfgang Grodd ◽

Dirk T. Leube

Keyword(s):

Alzheimer Disease ◽

Cortical Activation ◽

Cortical Activation During Cholinesterase-Inhibitor Treatment in Alzheimer Disease: Preliminary Findings From a Pharmaco-fMRI Study

American Journal of Geriatric Psychiatry ◽

10.1176/appi.ajgp.13.11.1006 ◽

2005 ◽

Vol 13 (11) ◽

pp. 1006-1013 ◽

Cited By ~ 11

Author(s):

T. T.J. Kircher

Keyword(s):

Alzheimer Disease ◽

Cortical Activation ◽

Fmri Study ◽

Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment

International Journal of Clinical Practice ◽

10.1111/j.1368-5031.2005.00769.x ◽

2005 ◽

Vol 60 (1) ◽

pp. 110-118 ◽

Cited By ~ 60

Author(s):

T. Dantoine ◽

S. Auriacombe ◽

M. Sarazin ◽

H. Becker ◽

J-J Pere ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Combination Therapy ◽

Cholinesterase inhibitor treatment in patients with delirium

The Lancet ◽

10.1016/s0140-6736(11)60342-5 ◽

2011 ◽

Vol 377 (9769) ◽

pp. 899 ◽

Cited By ~ 2

Author(s):

Anne-Cornélie JM de Pont ◽

Michael A van Geer ◽

Marcus J Schultz

Keyword(s):

Can Persistence With Cholinesterase Inhibitor Treatment Lower Mortality and Health-Care Costs Among Patients With Alzheimer’s Disease? A Population-Based Study in Taiwan

American Journal of Alzheimer s Disease & Other Dementias® ◽

10.1177/1533317517734639 ◽

2017 ◽

Vol 33 (2) ◽

pp. 86-92 ◽

Cited By ~ 5

Author(s):

Li-Jung Elizabeth Ku ◽

Chung-Yi Li ◽

Yu Sun

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Health Care ◽

Health Care Costs ◽

Population Based ◽

Lower Mortality ◽

Population Based Study ◽

Care Costs ◽

P1-290: High-dose cholinesterase inhibitor treatment of Alzheimer's disease

Alzheimer s & Dementia ◽

10.1016/j.jalz.2015.06.491 ◽

2015 ◽

Vol 11 (7S_Part_10) ◽

pp. P466-P467 ◽

Cited By ~ 1

Author(s):

Thomas N. Chase ◽

Kathleen Clarence-Smith

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

High Dose ◽

P056: The Memage study: a retrospective study on the benefits of combined memantine and cholinesterase inhibitor treatment in aged patients affected with Alzheimer's disease

European Geriatric Medicine ◽

10.1016/s1878-7649(14)70231-1 ◽

2014 ◽

Vol 5 ◽

pp. S100

Author(s):

P. Gareri ◽

D. Putignano ◽

A. Castagna ◽

A.M. Cotroneo ◽

G. de Palo ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Retrospective Study ◽

Aged Patients ◽